Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience.
Gentile I, Viceconte G, Lanzardo A, Zotta I, Zappulo E, Pinchera B, Scotto R, Schiano Moriello N, Foggia M, Giaccone A, Messina G, Salvatore P, Buonomo AR, Federico Ii Covid-Team. Gentile I, et al. Among authors: federico ii covid team. Int J Environ Res Public Health. 2021 Oct 29;18(21):11399. doi: 10.3390/ijerph182111399. Int J Environ Res Public Health. 2021. PMID: 34769913 Free PMC article.
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy).
Gentile I, Iorio M, Zappulo E, Scotto R, Maraolo AE, Buonomo AR, Pinchera B, Muto G, Iervolino C, Villari R, Schiano Moriello N, Scirocco MM, Triassi M, Paternoster M, Russo V, Viceconte G, Federico Ii Covid-Team. Gentile I, et al. Among authors: federico ii covid team. Int J Environ Res Public Health. 2022 Aug 18;19(16):10262. doi: 10.3390/ijerph191610262. Int J Environ Res Public Health. 2022. PMID: 36011895 Free PMC article.
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19.
Scotto R, Lanzardo A, Buonomo AR, Pinchera B, Cattaneo L, Sardanelli A, Mercinelli S, Viceconte G, Perrella A, Esposito V, Codella AV, Maggi P, Zappulo E, Villari R, Foggia M, Gentile I, Federico Ii Covid-Team. Scotto R, et al. Among authors: federico ii covid team. Vaccines (Basel). 2022 Nov 29;10(12):2043. doi: 10.3390/vaccines10122043. Vaccines (Basel). 2022. PMID: 36560453 Free PMC article.
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.
Scotto R, Buonomo AR, Iuliano A, Foggia M, Sardanelli A, Villari R, Pinchera B, Gentile I, Federico Ii Covid-Team. Scotto R, et al. Among authors: federico ii covid team. Vaccines (Basel). 2023 Jan 17;11(2):200. doi: 10.3390/vaccines11020200. Vaccines (Basel). 2023. PMID: 36851078 Free PMC article.